It's tough to beat gold, isn't it? There's no better medal to win in the Olympics. For many people, there's no better component of jewelry. And when it comes to investing, quite a few folks think that other investments just aren't as safe or lucrative.

Well, that's just wrong. You might think of gold as safe-ish because it's a tangible item that exists in limited quantities, and because piles of gold bars in a vault somewhere won't be worth nothing anytime soon. Think again. 

Stocks are tied to tangible things, too: actual bricks-and-mortar companies. Pfizer (NYSE:PFE) stock is tied to Pfizer buildings and Pfizer employees and lots of research and formulations of medications and patents. ExxonMobil (NYSE:XOM) stock is tied to oil-exploration equipment and data, to oil fields, pumps, and refineries, and to more buildings and employees, among other things. It's not likely that those kinds of assets will suddenly become worthless, or that the demand for energy and medications will shrivel up. Many great companies tend to hold their value.

Gold's mixed results
Those who think gold is a great investment need to think again, too. Sure, it can be one. And it has been one -- now and then. But over long periods, it doesn't have the best track record. Check out what $1 invested in various things between 1802 and 2006 would have grown to:


Real Return, in 204 Years











Data: Jeremy Siegel, Stocks for the Long Run.

And as you can tell from the dollar's return, those numbers are inflation-adjusted. A mere $100 investment would have netted you more than $75 million in stocks, while your money wouldn't even have doubled in value if you owned gold.

I know, we won't be investing for 204 years. And gold has done well lately; it recently topped $1,000 per ounce. That's more than twice where it was five years ago. But check out these returns:


Total Gain or Loss

1900 and 2000


1900 and 1950


1970 and 1980


1980 and 1990


1990 and 2000


Data: National Mining Association.

Clearly, you can do rather poorly with gold over various long periods. The 1970-to-1980 period is legitimately exciting, with an annualized 33% gain. But even the overall 1,372% gain isn't so hot, since it's over 100 years. Annualized, that comes out to just 2.7%.

You can do better
So go ahead and invest some of your money in gold if you really believe in it. Just know that with prices near all-time highs, it might be more likely to fall in value than to keep rising -- which is why it's good to seek out investments that seem cheap. But consider parking much of your money in places where it's most likely to grow well for you, such as stocks.

You could follow the advice of Warren Buffett and us at The Motley Fool and just opt for one or more simple index funds, which will track the overall stock markets for you. The Vanguard S&P 500 (VFINX) fund, for example, tracks 500 of America's biggest companies, including Intel (Nasdaq; INTC), Bank of America (NYSE:BAC), and Altria (NYSE:MO).

If you want to aim even higher than that, you might add a handful of carefully selected stocks to your mix. One way to find some is to screen for them. Here, for example, are some potentially undervalued companies I found when I screened for market caps of $2 billion or more, price-to-earnings (P/E) ratios of 20 or less, three-year revenue growth rates of 10% or more, and four or five stars (out of five) in our CAPS community of investors:


CAPS Stars

Market Cap


3-Year Growth

Petroleo Brasileiro (NYSE:PBR)


$81 billion





$63 billion





$43 billion



Eli Lilly (NYSE:LLY)


$38 billion



Data: Motley Fool CAPS.

Of course, you'll still need to research any such candidates further.

An easier alternative is to let trusted resources point you to compelling contenders for your portfolio. Our Motley Fool Inside Value newsletter recommends two such stocks each month, as our team seeks out undervalued and temporarily unloved companies. I invite you to test-drive the service for free for a whole month. You'll be able to access every issue, and every one of the recommendations that have been topping the market handily for more than five years now.

Longtime Fool contributor Selena Maranjian does owns no shares of any companies mentioned in this article. Intel and Pfizer are Motley Fool Inside Value recommendations. Petroleo Brasileiro is a Motley Fool Income Investor pick. CNOOC is a Motley Fool Global Gains selection. The Fool owns shares of Intel. The Motley Fool is Fools writing for Fools.